Christiaan Klijn
Genmab (United States)(US)Genmab (Netherlands)(NL)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, Biotechnology and Related Fields, Genomics, phytochemicals, and oxidative stress, DNA Repair Mechanisms
Most-Cited Works
- → Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy(2019)817 cited
- → A comprehensive transcriptional portrait of human cancer cell lines(2014)719 cited
- → USP7 small-molecule inhibitors interfere with ubiquitin binding(2017)334 cited
- → BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance(2011)262 cited
- → A resource for cell line authentication, annotation and quality control(2015)236 cited
- → A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types(2018)210 cited
- → Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers(2016)207 cited
- → Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events(2012)206 cited
- → BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1(2016)138 cited
- → A High-Throughput Functional Complementation Assay for Classification of BRCA1 Missense Variants(2013)134 cited